Background: CD3+CD4-CD8- double negative (DN) T cells, as a distinct subset of regulatory T cells (Tregs), played a pivotal role in patients following hematopoietic stem-cell transplantation. Methods: This study examines the behavior of CD3+CD4-CD8- double negative (DN) T cells in 73 patients at days 30, 60, 90 and 180 after allo-HSCT. Results: There was no significant difference in neutrophil and platelet engraftment between the higher and lower absolute counts of 30 days DN Tregs (p=0.674, 0.863, respectively). The reconstitution of DN Tregs was significantly slower than that of CD8+, CD4+, and CD3+CD8+CD28- T cells (p<0.001), but significantly faster than that of CD19+ and CD4+CD25+ T cells (p<0.001, p=0.032, respectively). I...
International audienceAcute graft-versus-host disease (aGVHD), mediated by CD4(+) and CD8(+) effecto...
HLA-haploidentical haematopoietic stem cell transplantation (haplo-HSCT) is increasingly offered to ...
To investigate the effects of non-inherited maternal antigen (NIMA) on clinical outcomes and immune ...
© 2016 by The American Society of HematologyThe development and maintenance of immune tolerance afte...
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is an established therapy for many ha...
This project received funding from: Fundacão para a Ciência e Tecnologia, Portugal under the Harvard...
Allogeneic hematopoietic cell transplantation (allo-HCT) is frequently used as treatment for patient...
Regulatory T cells (T-regs) play a key role in the prevention of acute graft-versus-host disease (aG...
INTRODUCTION: Haploidentical transplantation, with extensive T cell depletion to prevent GvHD, is a...
The success of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of he...
Background: Non-traditional CD4+CD25-CD69+ T cells were found to be involved in disease progression ...
Background: CD4+ FoxP3+ regulatory T cells (Tregs) are the potent suppressors of activation and prol...
Regulatory T cells (Tregs) that constitu-tively express FOXP3 are instrumental to the maintenance of...
In the complex interplay between inflammation and graft-versus-host disease (GVHD) after allogeneic ...
AbstractAllogeneic stem cell transplantation has become standard therapy for hematologic malignancie...
International audienceAcute graft-versus-host disease (aGVHD), mediated by CD4(+) and CD8(+) effecto...
HLA-haploidentical haematopoietic stem cell transplantation (haplo-HSCT) is increasingly offered to ...
To investigate the effects of non-inherited maternal antigen (NIMA) on clinical outcomes and immune ...
© 2016 by The American Society of HematologyThe development and maintenance of immune tolerance afte...
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is an established therapy for many ha...
This project received funding from: Fundacão para a Ciência e Tecnologia, Portugal under the Harvard...
Allogeneic hematopoietic cell transplantation (allo-HCT) is frequently used as treatment for patient...
Regulatory T cells (T-regs) play a key role in the prevention of acute graft-versus-host disease (aG...
INTRODUCTION: Haploidentical transplantation, with extensive T cell depletion to prevent GvHD, is a...
The success of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of he...
Background: Non-traditional CD4+CD25-CD69+ T cells were found to be involved in disease progression ...
Background: CD4+ FoxP3+ regulatory T cells (Tregs) are the potent suppressors of activation and prol...
Regulatory T cells (Tregs) that constitu-tively express FOXP3 are instrumental to the maintenance of...
In the complex interplay between inflammation and graft-versus-host disease (GVHD) after allogeneic ...
AbstractAllogeneic stem cell transplantation has become standard therapy for hematologic malignancie...
International audienceAcute graft-versus-host disease (aGVHD), mediated by CD4(+) and CD8(+) effecto...
HLA-haploidentical haematopoietic stem cell transplantation (haplo-HSCT) is increasingly offered to ...
To investigate the effects of non-inherited maternal antigen (NIMA) on clinical outcomes and immune ...